Phase II Trial of Neoadjuvant Weekly Nanoparticle Albumin-Bound Paclitaxel, Carboplatin, and Biweekly Bevacizumab Therapy in Women With Clinical Stage II or III HER2-Negative Breast Cancer

This phase II trial tested the rate of pathologic complete response (pCR) achieved by women with stage II–III human epidermal growth factor receptor 2-negative (HER2-negative) breast cancer (BC) treated with neo-adjuvant nanoparticle albumin-bound paclitaxel (nab-P), carboplatin and bevacizumab. The...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Mrózek, Ewa, Layman, Rachel, Ramaswamy, Bhuvaneswari, Lustberg, Maryam, Vecchione, Andrea, Knopp, Michael V., Shapiro, Charles L.
格式: Artigo
語言:Inglês
出版: 2014
主題:
Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC4104207/
https://ncbi.nlm.nih.gov/pubmed/24703985
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clbc.2014.02.005
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍